PharmiWeb.com - Global Pharma News & Resources

Company Directory - Research & Development

As a biotechnology company, Lifeasible is specialized in agricultural science, offering a wide variety of agro-related services and products for environmental and energy solutions.
MIMETAS strives to contribute to groundbreaking therapies with unique human disease biology, revealed by robust, screenable assays in the most versatile technology platform.
By integrating our proprietary COMPASS platform with our extensive technological and drug discovery capabilities, our team of scientific pioneers are working to accelerate the development of new precision medicines that change the course of disease.
MedAustron, the center for ion therapy and research is located in Wiener Neustadt in Lower Austria, about 50 kilometers south of Vienna. 180 employees coming from about 18 different countries are currently working for MedAustron. These include physicians, physicists, engineers, medical physicists, radiology technologists and administrative staff.
MedAustron in Wiener Neustadt, Austria, is one of the world’s most cutting-edge centers for cancer treatment and research. It started treating patients in Dezember 2016. MedAustron uses an innovative form of radiation therapy, namely ion beam therapy. Patients get irradiated with charged particles – protons or carbon ions.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm supports clients in mitigating development risks, creating data packages more likely to attract investors and support submissions that inspire regulators’ confidence.
MMV is a leading product development partnership (PDP) in antimalarial drug research. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs.